{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:56:11Z","timestamp":1788245771841,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK080089"],"award-info":[{"award-number":["DK080089"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK060635"],"award-info":[{"award-number":["DK060635"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joseph and Bessie Feinberg Foundation"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL0527719"],"award-info":[{"award-number":["HL0527719"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL112666"],"award-info":[{"award-number":["HL112666"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL109561"],"award-info":[{"award-number":["HL109561"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["BC150596P1"],"award-info":[{"award-number":["BC150596P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00109-017-1513-9","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T07:12:40Z","timestamp":1486105960000},"page":"473-486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II"],"prefix":"10.1007","volume":"95","author":[{"given":"Christoph","family":"Maier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Schadock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp K.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashpal","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Flask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Hoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory N.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin H.","family":"Schmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Batlle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"1513_CR1","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/S0021-9258(17)34557-X","volume":"253","author":"CE Odya","year":"1978","unstructured":"Odya CE, Marinkovic DV, Hammon KJ, Stewart TA, Erdos EG (1978) Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J Biol Chem 253:5927\u20135931","journal-title":"J Biol Chem"},{"key":"1513_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/2181224a0","volume":"218","author":"HY Yang","year":"1968","unstructured":"Yang HY, Erdos EG, Chiang TS (1968) New enzymatic route for the inactivation of angiotensin. Nature 218:1224\u20131226","journal-title":"Nature"},{"key":"1513_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1006\/geno.1997.4883","volume":"44","author":"B Watson Jr","year":"1997","unstructured":"Watson B Jr, Nowak NJ, Myracle AD, Shows TB, Warnock DG (1997) The human angiotensinase C gene (HUMPCP) maps to 11q14 within 700\u00a0kb of D11S901: a candidate gene for essential hypertension. Genomics 44:365\u2013367","journal-title":"Genomics"},{"key":"1513_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6807-10-16","volume":"10","author":"SM Soisson","year":"2010","unstructured":"Soisson SM, Patel SB, Abeywickrema PD, Byrne NJ, Diehl RE, Hall DL, Ford RE, Reid JC, Rickert KW, Shipman JM et al (2010) Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase. BMC Struct Biol 10:16","journal-title":"BMC Struct Biol"},{"key":"1513_CR5","doi-asserted-by":"publisher","first-page":"C945","DOI":"10.1152\/ajpcell.00346.2012","volume":"304","author":"N Grobe","year":"2013","unstructured":"Grobe N, Weir NM, Leiva O, Ong FS, Bernstein KE, Schmaier AH, Morris M, Elased KM (2013) Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. Am J Physiol Cell Physiol 304:C945\u2013C953","journal-title":"Am J Physiol Cell Physiol"},{"key":"1513_CR6","doi-asserted-by":"publisher","first-page":"e0117899","DOI":"10.1371\/journal.pone.0117899","volume":"10","author":"N Grobe","year":"2015","unstructured":"Grobe N, Leiva O, Morris M, Elased KM (2015) Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive mice. PLoS One 10:e0117899","journal-title":"PLoS One"},{"key":"1513_CR7","first-page":"2291","volume":"119","author":"N Wallingford","year":"2009","unstructured":"Wallingford N, Perroud B, Gao Q, Coppola A, Gyengesi E, Liu ZW, Gao XB, Diament A, Haus KA, Shariat-Madar Z et al (2009) Prolylcarboxypeptidase regulates food intake by inactivating alpha-MSH in rodents. J Clin Invest 119:2291\u20132303","journal-title":"J Clin Invest"},{"key":"1513_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbrc.2010.12.036","volume":"405","author":"SM Chajkowski","year":"2011","unstructured":"Chajkowski SM, Mallela J, Watson DE, Wang J, McCurdy CR, Rimoldi JM, Shariat-Madar Z (2011) Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase. Biochem Biophys Res Commun 405:338\u2013343","journal-title":"Biochem Biophys Res Commun"},{"key":"1513_CR9","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/pmic.201000145","volume":"10","author":"X Zhao","year":"2010","unstructured":"Zhao X, Southwick K, Cardasis HL, Du Y, Lassman ME, Xie D, El-Sherbeini M, Geissler WM, Pryor KD, Verras A et al (2010) Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase. Proteomics 10:2882\u20132886","journal-title":"Proteomics"},{"key":"1513_CR10","doi-asserted-by":"publisher","first-page":"17962","DOI":"10.1074\/jbc.M106101200","volume":"277","author":"Z Shariat-Madar","year":"2002","unstructured":"Shariat-Madar Z, Mahdi F, Schmaier AH (2002) Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 277:17962\u201317969","journal-title":"J Biol Chem"},{"key":"1513_CR11","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1182\/blood-2003-07-2510","volume":"103","author":"Z Shariat-Madar","year":"2004","unstructured":"Shariat-Madar Z, Mahdi F, Schmaier AH (2004) Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 103:4554\u20134561","journal-title":"Blood"},{"key":"1513_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1182\/blood-2012-10-460360","volume":"122","author":"GN Adams","year":"2013","unstructured":"Adams GN, Stavrou EX, Fang C, Merkulova A, Alaiti MA, Nakajima K, Morooka T, Merkulov S, Larusch GA, Simon DI et al (2013) Prolylcarboxypeptidase promotes angiogenesis and vascular repair. Blood 122:1522\u20131531","journal-title":"Blood"},{"key":"1513_CR13","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1074\/jbc.M110.143271","volume":"286","author":"L Duan","year":"2011","unstructured":"Duan L, Motchoulski N, Danzer B, Davidovich I, Shariat-Madar Z, Levenson VV (2011) Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells. J Biol Chem 286:2864\u20132876","journal-title":"J Biol Chem"},{"key":"1513_CR14","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1182\/blood-2010-11-318527","volume":"117","author":"GN Adams","year":"2011","unstructured":"Adams GN, LaRusch GA, Stavrou E, Zhou Y, Nieman MT, Jacobs GH, Cui Y, Lu Y, Jain MK, Mahdi F et al (2011) Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis. Blood 117:3929\u20133937","journal-title":"Blood"},{"key":"1513_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajog.2006.01.079","volume":"195","author":"L Wang","year":"2006","unstructured":"Wang L, Feng Y, Zhang Y, Zhou H, Jiang S, Niu T, Wei LJ, Xu X, Wang X (2006) Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia. Am J Obstet Gynecol 195:162\u2013171","journal-title":"Am J Obstet Gynecol"},{"key":"1513_CR16","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1373\/clinchem.2011.179291","volume":"58","author":"S Xu","year":"2012","unstructured":"Xu S, Lind L, Zhao L, Lindahl B, Venge P (2012) Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction. Clin Chem 58:1110\u20131115","journal-title":"Clin Chem"},{"key":"1513_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11064-014-1468-y","volume":"40","author":"K Kehoe","year":"2015","unstructured":"Kehoe K, Brouns R, Verkerk R, Engelborghs S, De Deyn PP, Hendriks D, De Meester I (2015) Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke. Neurochem Res 40:81\u201388","journal-title":"Neurochem Res"},{"key":"1513_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.peptides.2014.08.016","volume":"61","author":"RA Marangoni","year":"2014","unstructured":"Marangoni RA, Santos RA, Piccolo C (2014) Deficient prolylcarboxypeptidase gene and protein expression in left ventricles of spontaneously hypertensive rats (SHR). Peptides 61:69\u201374","journal-title":"Peptides"},{"key":"1513_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1113\/expphysiol.2007.040014","volume":"93","author":"SB Gurley","year":"2008","unstructured":"Gurley SB, Coffman TM (2008) Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages. Exp Physiol 93:538\u2013542","journal-title":"Exp Physiol"},{"key":"1513_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.113.02856","volume":"63","author":"PK Haber","year":"2014","unstructured":"Haber PK, Ye M, Wysocki J, Maier C, Haque SK, Batlle D (2014) Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro. Hypertension 63:774\u2013782","journal-title":"Hypertension"},{"key":"1513_CR21","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1021\/jm101013m","volume":"53","author":"C Zhou","year":"2010","unstructured":"Zhou C, Garcia-Calvo M, Pinto S, Lombardo M, Feng Z, Bender K, Pryor KD, Bhatt UR, Chabin RM, Geissler WM et al (2010) Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity. J Med Chem 53:7251\u20137263","journal-title":"J Med Chem"},{"key":"1513_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.112.198622","volume":"60","author":"M Ye","year":"2012","unstructured":"Ye M, Wysocki J, Gonzalez-Pacheco FR, Salem M, Evora K, Garcia-Halpin L, Poglitsch M, Schuster M, Batlle D (2012) Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60:730\u2013740","journal-title":"Hypertension"},{"key":"1513_CR23","doi-asserted-by":"publisher","first-page":"e00264","DOI":"10.1002\/phy2.264","volume":"2","author":"J Wysocki","year":"2014","unstructured":"Wysocki J, Ortiz-Melo DI, Mattocks NK, Xu K, Prescott J, Evora K, Ye M, Sparks MA, Haque SK, Batlle D et al (2014) ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney. Physiol Rep 2:e00264","journal-title":"Physiol Rep"},{"key":"1513_CR24","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1210\/en.2003-0009","volume":"144","author":"LA Neves","year":"2003","unstructured":"Neves LA, Williams AF, Averill DB, Ferrario CM, Walkup MP, Brosnihan KB (2003) Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology 144:3338\u20133343","journal-title":"Endocrinology"},{"key":"1513_CR25","doi-asserted-by":"crossref","first-page":"F636","DOI":"10.1152\/ajprenal.2000.279.4.F636","volume":"279","author":"AJ Allred","year":"2000","unstructured":"Allred AJ, Chappell MC, Ferrario CM, Diz DI (2000) Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol 279:F636\u2013F645","journal-title":"Am J Physiol Renal Physiol"},{"key":"1513_CR26","doi-asserted-by":"publisher","first-page":"F590","DOI":"10.1152\/ajprenal.00324.2003","volume":"286","author":"Z Qi","year":"2004","unstructured":"Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, Breyer MD (2004) Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 286:F590\u2013F596","journal-title":"Am J Physiol Renal Physiol"},{"key":"1513_CR27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1681\/ASN.2009121290","volume":"21","author":"KL Hudkins","year":"2010","unstructured":"Hudkins KL, Pichaiwong W, Wietecha T, Kowalewska J, Banas MC, Spencer MW, Muhlfeld A, Koelling M, Pippin JW, Shankland SJ et al (2010) BTBR Ob\/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 21:1533\u20131542","journal-title":"J Am Soc Nephrol"},{"key":"1513_CR28","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1681\/ASN.2006050423","volume":"17","author":"M Ye","year":"2006","unstructured":"Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D (2006) Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17:3067\u20133075","journal-title":"J Am Soc Nephrol"},{"key":"1513_CR29","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1097\/01.ASN.0000099375.74789.AB","volume":"14","author":"PA Stehberger","year":"2003","unstructured":"Stehberger PA, Schulz N, Finberg KE, Karet FE, Giebisch G, Lifton RP, Geibel JP, Wagner CA (2003) Localization and regulation of the ATP6V0A4 (a4) vacuolar H+-ATPase subunit defective in an inherited form of distal renal tubular acidosis. J Am Soc Nephrol 14:3027\u20133038","journal-title":"J Am Soc Nephrol"},{"key":"1513_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/CIRCIMAGING.111.972406","volume":"5","author":"S Azam","year":"2012","unstructured":"Azam S, Desjardins CL, Schluchter M, Liner A, Stelzer JE, Yu X, Hoit BD (2012) Comparison of velocity vector imaging echocardiography with magnetic resonance imaging in mouse models of cardiomyopathy. Circ Cardiovasc Imaging 5:776\u2013781","journal-title":"Circ Cardiovasc Imaging"},{"key":"1513_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","volume":"165","author":"HD Xiao","year":"2004","unstructured":"Xiao HD, Fuchs S, Campbell DJ, Lewis W, Dudley SC Jr, Kasi VS, Hoit BD, Keshelava G, Zhao H, Capecchi MR et al (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165:1019\u20131032","journal-title":"Am J Pathol"},{"key":"1513_CR32","unstructured":"Irfan S, Patricia V, Daniel B (2014) Vacuolar H+-ATPase in distal renal tubular acidosis and diabetes. In: Nakamura S (ed) Handbook of H+-ATPases, 1st edn.\u00a0Pan Stanford Publishing, Singapore, pp 271\u2013292"},{"key":"1513_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.HYP.0000154787.42718.a4","volume":"45","author":"P Valles","year":"2005","unstructured":"Valles P, Wysocki J, Salabat MR, Cokic I, Ye M, LaPointe MS, Batlle D (2005) Angiotensin II increases H+-ATPase B1 subunit expression in medullary collecting ducts. Hypertension 45:818\u2013823","journal-title":"Hypertension"},{"key":"1513_CR34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V91.2.516","volume":"91","author":"G Motta","year":"1998","unstructured":"Motta G, Rojkjaer R, Hasan AA, Cines DB, Schmaier AH (1998) High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood 91:516\u2013528","journal-title":"Blood"},{"key":"1513_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0162-3109(99)00069-7","volume":"43","author":"R Rojkjaer","year":"1999","unstructured":"Rojkjaer R, Schmaier AH (1999) Activation of the plasma kallikrein\/kinin system on endothelial cell membranes. Immunopharmacology 43:109\u2013114","journal-title":"Immunopharmacology"},{"key":"1513_CR36","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1172\/JCI16980","volume":"116","author":"SB Gurley","year":"2006","unstructured":"Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL et al (2006) Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116:2218\u20132225","journal-title":"J Clin Invest"},{"key":"1513_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/01.HYP.0000081221.36703.01","volume":"42","author":"P Komlosi","year":"2003","unstructured":"Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD (2003) Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 42:195\u2013199","journal-title":"Hypertension"},{"key":"1513_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/01.ASN.0000013292.78621.FD","volume":"13","author":"J Peti-Peterdi","year":"2002","unstructured":"Peti-Peterdi J, Warnock DG, Bell PD (2002) Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 13:1131\u20131135","journal-title":"J Am Soc Nephrol"},{"key":"1513_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/ajh\/hpt071","volume":"26","author":"N Ramkumar","year":"2013","unstructured":"Ramkumar N, Ying J, Stuart D, Kohan DE (2013) Overexpression of renin in the collecting duct causes elevated blood pressure. Am J Hypertens 26:965\u2013972","journal-title":"Am J Hypertens"},{"key":"1513_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW et al (1994) Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407\u2013414","journal-title":"Cell"},{"key":"1513_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00000441-200112000-00002","volume":"322","author":"DG Warnock","year":"2001","unstructured":"Warnock DG (2001) Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci 322:302\u2013307","journal-title":"Am J Med Sci"},{"key":"1513_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1172\/JCI110015","volume":"67","author":"K Kumamoto","year":"1981","unstructured":"Kumamoto K, Stewart TA, Johnson AR, Erdos EG (1981) Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells. J Clin Invest 67:210\u2013215","journal-title":"J Clin Invest"},{"key":"1513_CR43","doi-asserted-by":"publisher","first-page":"E1502","DOI":"10.1152\/ajpendo.00544.2011","volume":"302","author":"JK Jeong","year":"2012","unstructured":"Jeong JK, Szabo G, Raso GM, Meli R, Diano S (2012) Deletion of prolyl carboxypeptidase attenuates the metabolic effects of diet-induced obesity. Am J Physiol Endocrinol Metab 302:E1502\u2013E1510","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1513_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1161\/01.HYP.0000048194.97428.1A","volume":"41","author":"JJ Kuo","year":"2003","unstructured":"Kuo JJ, Silva AA, Hall JE (2003) Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension 41:768\u2013774","journal-title":"Hypertension"},{"key":"1513_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa0803085","volume":"360","author":"JR Greenfield","year":"2009","unstructured":"Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC et al (2009) Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 360:44\u201352","journal-title":"N Engl J Med"},{"key":"1513_CR46","doi-asserted-by":"crossref","first-page":"16631","DOI":"10.1016\/S0021-9258(19)85465-0","volume":"268","author":"F Tan","year":"1993","unstructured":"Tan F, Morris PW, Skidgel RA, Erdos EG (1993) Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem 268:16631\u201316638","journal-title":"J Biol Chem"},{"key":"1513_CR47","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/ajh\/hpv054","volume":"28","author":"J Wysocki","year":"2015","unstructured":"Wysocki J, Ye M, Batlle D (2015) Plasma and kidney angiotensin peptides: importance of the aminopeptidase a\/angiotensin III axis. Am J Hypertens 28:1418\u20131426","journal-title":"Am J Hypertens"},{"key":"1513_CR48","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.bbapap.2016.07.004","volume":"1864","author":"K Kehoe","year":"2016","unstructured":"Kehoe K, Van Elzen R, Verkerk R, Sim Y, Van der Veken P, Lambeir AM, De Meester I (2016) Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme. Biochim Biophys Acta 1864:1481\u20131488","journal-title":"Biochim Biophys Acta"},{"key":"1513_CR49","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1074\/mcp.M112.023234","volume":"12","author":"S Tanco","year":"2013","unstructured":"Tanco S, Lorenzo J, Garcia-Pardo J, Degroeve S, Martens L, Aviles FX, Gevaert K, Van Damme P (2013) Proteome-derived peptide libraries to study the substrate specificity profiles of carboxypeptidases. Mol Cell Proteomics 12:2096\u20132110","journal-title":"Mol Cell Proteomics"},{"key":"1513_CR50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nmeth.2182","volume":"9","author":"AJ O\u2019Donoghue","year":"2012","unstructured":"O\u2019Donoghue AJ, Eroy-Reveles AA, Knudsen GM, Ingram J, Zhou M, Statnekov JB, Greninger AL, Hostetter DR, Qu G, Maltby DA et al (2012) Global identification of peptidase specificity by multiplex substrate profiling. Nat Methods 9:1095\u20131100","journal-title":"Nat Methods"},{"key":"1513_CR51","doi-asserted-by":"crossref","first-page":"A424","DOI":"10.1161\/hyp.64.suppl_1.424","volume":"64","author":"MA Sparks","year":"2014","unstructured":"Sparks MA, Stegbauer J, Chen D, Vivekanandan-Giri A, Pennathur S, Crowley SD, Gurley SB, Coffman TM (2014) Abstract 424: cardiac hypertrophy in angiotensin ii-dependent hypertension: dominant effect of blood pressure. Hypertension 64:A424","journal-title":"Hypertension"},{"key":"1513_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jash.2011.08.006","volume":"5","author":"F Cacciapuoti","year":"2011","unstructured":"Cacciapuoti F (2011) Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. J Am Soc Hypertens 5:449\u2013455","journal-title":"J Am Soc Hypertens"},{"key":"1513_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-015-0509-4","volume":"76","author":"L Paulis","year":"2016","unstructured":"Paulis L, Foulquier S, Namsolleck P, Recarti C, Steckelings UM, Unger T (2016) Combined angiotensin receptor modulation in the management of cardio-metabolic disorders. Drugs 76:1\u201312","journal-title":"Drugs"},{"key":"1513_CR54","doi-asserted-by":"publisher","first-page":"H2356","DOI":"10.1152\/ajpheart.00317.2005","volume":"289","author":"M Iwata","year":"2005","unstructured":"Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX, Greenberg BH (2005) Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289:H2356\u2013H2363","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1513_CR55","doi-asserted-by":"publisher","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","volume":"290","author":"JL Grobe","year":"2006","unstructured":"Grobe JL, Mecca AP, Mao H, Katovich MJ (2006) Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290:H2417\u2013H2423","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1513_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/HYPERTENSIONAHA.115.05093","volume":"66","author":"J Wysocki","year":"2015","unstructured":"Wysocki J, Wilsbacher L, Batlle D (2015) Angiotensins and the heart: is angiotensin-(1-7) cardioprotective? Hypertension 66:260\u2013262","journal-title":"Hypertension"},{"key":"1513_CR57","doi-asserted-by":"publisher","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","volume":"292","author":"JL Grobe","year":"2007","unstructured":"Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ (2007) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292:H736\u2013H742","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-017-1513-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-017-1513-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-017-1513-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T10:36:37Z","timestamp":1658572597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-017-1513-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s00109-017-1513-9","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]},"assertion":[{"value":"9 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"D.B. had grant support for these studies from the National Institute of Diabetes and Digestive and Kidney Diseases (DK 080089) and the Reuben Feinberg Foundation. C.M. and P.K.H. received funding from the German Academic Exchange Service (DAAD). A.H.S. has support from the NIH NHLBI HL0527719, HL112666, HL109561, and DOD BC150596P1.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}